QU

Qiming U.S. Ventures Management, LLC

13F
Qiming U.S. Ventures Management, LLC
Last update 2024-11-07 6 Stocks (0 new)
Value $51.00 Mil Turnover 0 %
Countries:
Top Holdings: TRML(37.12%)JSPR(34.02%)KRRO(23.95%)HLVX(1.92%)VTYX(1.75%)
Portfolio Report
Summary Stock Picks Current Portfolio
Qiming U.S. Ventures Managemen... Top Holdings of 2024-09-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
TRML 		Tourmaline Bio Inc
741,691
19068.880
0%
37.120
0%
2.890
+97.80%
+9.85%
737.481
Biotechnology
JSPR 		Jasper Therapeutics Inc
928,964
17473.810
0%
34.020
0%
6.150
+49.39%
+210.90%
370.533
Biotechnology
KRRO 		Korro Bio Inc
368,085
12301.400
0%
23.950
0%
3.960
+95.61%
+46.88%
654.637
Biotechnology
HLVX 		HilleVax Inc
558,923
983.700
0%
1.920
0%
1.120
+15.06%
-88.10%
95.130
Biotechnology
VTYX 		Ventyx Biosciences Inc
412,225
898.650
0%
1.750
0%
0.580
+11.11%
-10.93%
155.563
Biotechnology
KZR 		Kezar Life Sciences Inc
82,871
638.110
0%
1.240
0%
11.350
+27.64%
-22.21%
53.773
Biotechnology

Qiming U.S. Ventures Management, LLC's Historical Top Holdings Breakdowns

Qiming U.S. Ventures Management, LLC's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
ICVX Icosavax Inc2024-03-31Sold Out
-50.66%
●
15.2 ($15.42) 15.88
$15.31
-0.71%
Sold Out
0
-3,510,228
TRML 		Tourmaline Bio Inc2024-03-31Add
+2.55%
●
22.9 ($35.26) 45.64
$28.76
-18.43%
Add 15.58%
741,691
100,000
JSPR 		Jasper Therapeutics Inc2024-03-31Add
+2.52%
●
6.63 ($17.76) 29.67
$24.53
38.12%
Add 9.04%
928,964
76,999
ELEV 		Elevation Oncology Inc2024-03-31Sold Out
-1.17%
●
0.59 ($3.24) 5.13
$0.65
-79.94%
Sold Out
0
-2,370,142
VTYX 		Ventyx Biosciences Inc2024-03-31Reduce
-0.62%
●
1.9 ($4.57) 10.13
$2.20
-51.86%
Reduce -39.94%
412,225
-274,145
KRRO 		Korro Bio Inc2023-12-31New Buy
+16.15%
●
15.48 ($45.47) 58
$70.40
54.83%
New holding
368,085
368,085
TRML 		Tourmaline Bio Inc2023-12-31New Buy
+15.38%
●
9.46 ($17.96) 28.36
$28.76
60.13%
New holding
641,691
641,691
TALS Talaris Therapeutics Inc2023-12-31Sold Out
-10.94%
●
2.59 ($2.72) 3
$2.72
0%
Sold Out
0
-293,261
VTYX 		Ventyx Biosciences Inc2023-09-30Reduce
-2.07%
●
29.8 ($34.57) 40.3
$2.20
-93.64%
Reduce -8.04%
686,370
-60,000
JSPR 		Jasper Therapeutics Inc2023-03-31Add
+5.84%
●
14.8 ($18.48) 27.4
$24.53
32.74%
Add 45.56%
851,965
2,666,666

Qiming U.S. Ventures Management, LLC Total Holding History ($B)

To

Qiming U.S. Ventures Management, LLC's Asset Allocation

To

Qiming U.S. Ventures Management, LLC Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Qiming U.S. Ventures Management, LLC's Hypothetical Growth since 2024-09-30

Qiming U.S. Ventures Management, LLC's Yearly Returns

Year Portfolio % % Excess Gain %

Qiming U.S. Ventures Management, LLC's Holdings Heat Map

Size field:

Qiming U.S. Ventures Management, LLC's Holdings Bubble Chart

Qiming U.S. Ventures Management, LLC News

  • 1

Discussions on Qiming U.S. Ventures Management, LLC

No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.